The purpose of the study is to estimate the Chinese economic burden in patients with Alzheimer's Disease (AD).
This observational study covered all the 30 provincials/municipals/autonomous in mainland China except Hong Kong and Macau. Tier 3 hospitals, psychiatric hospitals, elderly hospitals, nursing home and communities were randomly selected as research centers, and more than 2500 patients with AD and their caregivers were enrolled at last. The main outcome of this study was assessed not only by the electronic medical system of communities and hospitals, but also by questionnaires. Using a societal prevalence-based gross COI approach to estimated the total yearly costs of AD in China.
Study Type
OBSERVATIONAL
Enrollment
3,098
The study is non-interventional.
Xuanwu Hospital, Capital Medical University
Beijing, Beijing Municipality, China
The Annual National Total Socioeconomic Cost for All AD Patients in China
The annual national total socioeconomic cost for all patients with AD in China in 2015 was obtained, with the average annual cost per patient with AD from our results multiplied by the all number of patients with AD in 2015. So, the value reported in the data table below represents the total cost for all all participants in China.
Time frame: one year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.